- Login
- Register & Subscribe
- Language: EN FR DE
Cancer Research Technology (CRT) has entered into a three-year drug discovery and development alliance with AstraZeneca Plc that is expected to lead to the identification of new small molecule drugs targeting changes in a cell’s metabolism.
United Kingdom
Friday August 20 2010
Friday August 20 2010
Thursday August 19 2010
Thursday August 12 2010
Tuesday August 10 2010